Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 8 clinical trials
Lenalidomide in Combination With R-DA-EPOCH in Patients With Untreated DLBCL With MYC Rearrangement

compared to R-CHOP regimen in this cohort of patients. The investigators therefore design this phase I/II study to investigate the safety and efficacy of lenalidomide in combination with R-DA EPOCH in

doxorubicin
etoposide
vincristine
rituximab
prednisone
  • 0 views
  • 25 Jan, 2021
  • 1 location
Azacitidine Combined With Chidamide in the Treatment of Newly Diagnosed PTCL Unfit for Conventional Chemotherapy

This prospective, open-label, single-arm study will evaluate the efficacy and safety of azacitidine in combination with chidamide in treatment of newly diagnosed peripheral T-cell lymphoma unfit for conventional chemotherapy.

t-cell lymphoma
chidamide
peripheral t-cell lymphoma
measurable disease
  • 0 views
  • 25 Jan, 2021
  • 1 location
PD-1 Antibody Chidamide Lenalidomide and Gemcitabine for Peripheral T-cell Lymphoma

To observe the safety, tolerability and clinical effects of PD-1, chidamide, lenalidomide and gemcitabine in the treatment of newly diagnosed and relapse/refractory peripheral T-cell lymphoma.

refractory peripheral t-cell lymphoma
lenalidomide
chidamide
peripheral t-cell lymphoma
t-cell lymphoma
  • 1 views
  • 24 Jan, 2021
  • 1 location
Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL

This study is a Randomized Phase II Study to Compare Efficacy of CHOP versus Fractionated ICED in Transplant-eligible Patients with Previously Untreated Peripheral T-cell Lymphoma.

anaplastic large cell lymphoma
peripheral t-cell lymphoma
t-cell lymphoma
etoposide
dexamethasone
  • 10 views
  • 26 Jan, 2021
  • 1 location
Targeted Drug Combined With CHOP in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma

This prospectivemulti-centeropen-label, controlled study will evaluate the efficacy and safety of targeted drug in combination with CHOP in treatment of newly diagnosed peripheral T-cell lymphoma.

doxorubicin
t-cell lymphoma
peripheral t-cell lymphoma
vincristine
prednisone
  • 0 views
  • 24 Jan, 2021
Zanubrutinib Combined With Tislelizumab in the Treatment of r/r PMBCL and EBV+ DLBCL

The study is to investigate the safety and efficacy of Zanubrutinib combined with Tislelizumab in the treatment of relapsed/refractory primary mediastinal large B-cell lymphoma and Epstein-Barr Virus-positive diffuse large B-cell lymphoma.

  • 0 views
  • 07 Apr, 2021
  • 1 location
Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma

Primary objective of the study is to compare the efficacy and safety of CDOP versus CHOP for newly diagnosed peripheral T-cell lymphoma (PTCL).

anaplastic large cell lymphoma
ct scan
t-cell lymphoma
doxorubicin
vincristine
  • 0 views
  • 23 Jan, 2021
  • 1 location
Combination Chemotherapy Including Cisplatin Ifosfamide Gemcitabine L-asparaginase Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas

The PIGLETS regimen was devised to replace the conventional SMILE regimen in management of extranodal NK/T cell lymphoma in our institution. It had been three years since the introduction of PIGLETS regimen in treatment of NK malignancies. The response rate is encouraging, with an overall response rate (ORR) of 90% …

cancer
etoposide
dexamethasone
t-cell lymphoma
  • 2 views
  • 22 Jan, 2021